<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-74NMUHJC</identifier><date>2008</date><creator>Černelč, Peter</creator><creator>Kabaklić, Amela</creator><relation>documents/znanstveni_clanki/zdravniski_vestnik/html/urn_nbn_si_doc-74nmuhjc.html</relation><relation>documents/znanstveni_clanki/zdravniski_vestnik/pdf/urn_nbn_si_doc-74nmuhjc.pdf</relation><relation>documents/znanstveni_clanki/zdravniski_vestnik/txt/urn_nbn_si_doc-74nmuhjc.txt</relation><format format_type="issue">1</format><format format_type="main">6 strani</format><format format_type="volume">77</format><format format_type="type">article</format><format format_type="extent">str. I-81-I-86</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">24129497</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-74NMUHJC</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="eng">Beta 2-Microglobulin</subject><subject language_type_id="slv">Beta 2-mikroglobulini</subject><subject language_type_id="eng">Drug Therapy</subject><subject language_type_id="slv">hematologija</subject><subject language_type_id="slv">Melfalan</subject><subject language_type_id="eng">Melphalan</subject><subject language_type_id="eng">Multiple Myeloma</subject><subject language_type_id="slv">Multipli mielom</subject><subject language_type_id="slv">plazmocitom</subject><subject language_type_id="slv">Preživetje, analiza</subject><subject language_type_id="eng">Survival Analysis</subject><subject language_type_id="slv">Talidomid</subject><subject language_type_id="eng">Thalidomide</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Evaluation of treatment for elderly patients with multiple myeloma</title><title>Ocena uspešnosti enajstletnega zdravljenja starejših bolnikov z diseminiranim plazmocitomom</title></Record>